Brokerages Expect Colgate-Palmolive (CL) Will Announce Earnings of $0.75 Per Share
Equities analysts expect Colgate-Palmolive (NYSE:CL) to announce earnings per share (EPS) of $0.75 for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Colgate-Palmolive’s earnings. The lowest EPS estimate is $0.74 and the highest is $0.76. Colgate-Palmolive also reported earnings per share of $0.75 in the same quarter last year. The company is expected to announce its next earnings report before the market opens on Friday, January 26th.
According to Zacks, analysts expect that Colgate-Palmolive will report full-year earnings of $2.87 per share for the current year, with EPS estimates ranging from $2.86 to $2.88. For the next fiscal year, analysts expect that the company will post earnings of $3.15 per share, with EPS estimates ranging from $3.03 to $3.50. Zacks’ earnings per share averages are an average based on a survey of analysts that cover Colgate-Palmolive.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same quarter in the prior year, the company earned $0.73 earnings per share. The company’s revenue was up 2.8% on a year-over-year basis.
In other Colgate-Palmolive news, insider Jennifer Daniels sold 902 shares of the company’s stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total value of $68,389.64. Following the completion of the transaction, the insider now owns 37,788 shares in the company, valued at $2,865,086.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Stephen I. Sadove sold 20,780 shares of the company’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the transaction, the director now owns 36,268 shares of the company’s stock, valued at approximately $2,557,619.36. The disclosure for this sale can be found here. In the last quarter, insiders have sold 181,950 shares of company stock valued at $13,237,385. Insiders own 1.02% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CL. Confluence Investment Management LLC boosted its stake in Colgate-Palmolive by 3.0% in the second quarter. Confluence Investment Management LLC now owns 1,308,539 shares of the company’s stock valued at $97,002,000 after acquiring an additional 37,504 shares in the last quarter. First Financial Bank Trust Division raised its holdings in shares of Colgate-Palmolive by 4.6% in the second quarter. First Financial Bank Trust Division now owns 35,513 shares of the company’s stock valued at $2,633,000 after buying an additional 1,562 shares during the last quarter. Pennsylvania Trust Co raised its holdings in shares of Colgate-Palmolive by 26.4% in the second quarter. Pennsylvania Trust Co now owns 90,423 shares of the company’s stock valued at $6,703,000 after buying an additional 18,891 shares during the last quarter. Bank of The West raised its holdings in shares of Colgate-Palmolive by 4.7% in the second quarter. Bank of The West now owns 2,881 shares of the company’s stock valued at $213,000 after buying an additional 130 shares during the last quarter. Finally, Arvest Bank Trust Division raised its holdings in shares of Colgate-Palmolive by 1.0% in the second quarter. Arvest Bank Trust Division now owns 244,317 shares of the company’s stock valued at $18,111,000 after buying an additional 2,536 shares during the last quarter. Institutional investors own 72.86% of the company’s stock.
Shares of Colgate-Palmolive (CL) opened at $77.50 on Friday. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.91. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. The firm has a market capitalization of $67,289.20, a price-to-earnings ratio of 29.92, a PEG ratio of 3.20 and a beta of 0.80.
The company also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.06%. Colgate-Palmolive’s payout ratio is currently 61.78%.
TRADEMARK VIOLATION NOTICE: “Brokerages Expect Colgate-Palmolive (CL) Will Announce Earnings of $0.75 Per Share” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2018/01/20/brokerages-expect-colgate-palmolive-cl-will-announce-earnings-of-0-75-per-share.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.